Ng George K — SEC Form 4 filings

SEC reporting owner CIK 1638744. 21 Form 4 filings on record with FilingPulse; latest filed 2026-08-11.

Transaction summary — filings shown

Covers all 21 filings on record, filed 2024-01-31 to 2026-08-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Processa Pharmaceuticals, Inc. (PCSA)Chief Executive Officer, Director1812 legs · 118,529 sh · $151,5828
TuHURA Biosciences, Inc./NV (HURA)Director35

Form 4 filings — Ng George K

FiledFormIssuerReported transactionsSource
2026-08-114Processa Pharmaceuticals, Inc. (PCSA)Option exercise (M): 1,600 · Option exercise (M): 1,600 (derivative) @ $0EDGAR
2026-07-284Processa Pharmaceuticals, Inc. (PCSA)Grant/award (A): 9,384 (derivative) @ $0EDGAR
2026-07-014Processa Pharmaceuticals, Inc. (PCSA)Purchase (P): 3,057 @ $1.93EDGAR
2026-06-164Processa Pharmaceuticals, Inc. (PCSA)Purchase (P): 2,465 @ $2.22EDGAR
2026-06-014Processa Pharmaceuticals, Inc. (PCSA)Purchase (P): 2,129 @ $2.57EDGAR
2026-05-194/AProcessa Pharmaceuticals, Inc. (PCSA)Purchase (P): 1,843 @ $2.97EDGAR
2026-05-194Processa Pharmaceuticals, Inc. (PCSA)Purchase (P): 1,843 @ $2.97EDGAR
2026-05-014Processa Pharmaceuticals, Inc. (PCSA)Purchase (P): 2,034 @ $2.69EDGAR
2026-04-304/AProcessa Pharmaceuticals, Inc. (PCSA)Purchase (P): 2,136 @ $2.54EDGAR
2026-04-304/AProcessa Pharmaceuticals, Inc. (PCSA)Purchase (P): 1,843 @ $2.97EDGAR
2026-04-174Processa Pharmaceuticals, Inc. (PCSA)Purchase (P): 1,843 @ $2.97EDGAR
2026-04-014Processa Pharmaceuticals, Inc. (PCSA)Purchase (P): 2,136 @ $2.54EDGAR
2026-02-174TuHURA Biosciences, Inc./NV (HURA)Grant/award (A): 156,240 (derivative) @ $0EDGAR
2025-10-034Processa Pharmaceuticals, Inc. (PCSA)Grant/award (A): 256,000 (derivative) @ $0 · Grant/award (A): 768,000 (derivative) @ $0EDGAR
2025-09-184/AProcessa Pharmaceuticals, Inc. (PCSA)Holdings only — no transactions reportedEDGAR
2025-07-284Processa Pharmaceuticals, Inc. (PCSA)Grant/award (A): 1,822,471 (derivative) @ $0EDGAR
2025-02-184/AProcessa Pharmaceuticals, Inc. (PCSA)Grant/award (A): 87,200 (derivative) @ $0 · Grant/award (A): 43,600 (derivative) @ $0EDGAR
2025-01-294Processa Pharmaceuticals, Inc. (PCSA)Purchase (P): 87,200 @ $0.80EDGAR
2025-01-064TuHURA Biosciences, Inc./NV (HURA)Grant/award (A): 51,275 (derivative) @ $0EDGAR
2024-10-224Kintara Therapeutics, Inc. (KTRA)Grant/award (A): 35,780 (derivative) @ $0 · Grant/award (A): 13,553 (derivative) @ $0 · Grant/award (A): 13,553 (derivative) @ $0EDGAR
2024-01-314Processa Pharmaceuticals, Inc. (PCSA)Purchase (P): 10,000 @ $2.70EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1638744 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →